Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02610140 · FLOW

Participant flow

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM) · Source last updated 2020-11-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Experimental
    id
    FG000
    title
    Anetumab Ravtansine (Experimental)
  2. description
    Active comparator
    id
    FG001
    title
    Vinorelbine (Active Comparator)
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        15
      type
      Radiological progression
    2. reasons
      1. group Id
        FG000
        num Subjects
        54
      2. group Id
        FG001
        num Subjects
        23
      type
      Progressive disease - radiological
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Protocol Violation
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      type
      Physician Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Lack of Efficacy
    6. reasons
      1. group Id
        FG000
        num Subjects
        7
      2. group Id
        FG001
        num Subjects
        1
      type
      Death
    7. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    8. reasons
      1. group Id
        FG000
        num Subjects
        44
      2. group Id
        FG001
        num Subjects
        13
      type
      Adverse Event
    9. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        5
      type
      Progressive disease - clinical
    10. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        2
      type
      Ongoing but not completed
    11. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        10
      type
      Not treated
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        166
      2. group Id
        FG001
        num Subjects
        82
      comment
      Randomized
      type
      STARTED
    2. achievements
      1. comment
        Safety analysis set
        group Id
        FG000
        num Subjects
        163
      2. comment
        Safety analysis set
        group Id
        FG001
        num Subjects
        72
      type
      Participants Received Treatment
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        166
      2. group Id
        FG001
        num Subjects
        82
      type
      NOT COMPLETED
    title
    Randomization and Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        2
      type
      Other
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      type
      No follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        2
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        5
      type
      Deterioration of general conditions
    6. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        102
      2. group Id
        FG001
        num Subjects
        45
      comment
      Safety follow-up performed
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        57
      2. group Id
        FG001
        num Subjects
        21
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        45
      2. group Id
        FG001
        num Subjects
        24
      type
      NOT COMPLETED
    title
    Safety Follow-up
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        30
      2. group Id
        FG001
        num Subjects
        22
      type
      Progressive disease - radiological
    2. reasons
      1. group Id
        FG000
        num Subjects
        8
      2. group Id
        FG001
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        0
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      type
      Progressive disease - clinical
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Deterioration of general conditions
    6. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        1
      type
      Ongoing but not completed
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        48
      2. group Id
        FG001
        num Subjects
        26
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        48
      2. group Id
        FG001
        num Subjects
        26
      type
      NOT COMPLETED
    title
    Active Follow-up
  4. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        86
      2. group Id
        FG001
        num Subjects
        44
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        3
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        30
      2. group Id
        FG001
        num Subjects
        17
      type
      Ongoing but not completed
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        123
      2. group Id
        FG001
        num Subjects
        66
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        123
      2. group Id
        FG001
        num Subjects
        66
      type
      NOT COMPLETED
    title
    Long-term Follow-up
pre Assignment Details
Overall, 315 patients were screened; of these, 67 patients were screening failures.
Complete source fields
groups
  1. description
    Experimental
    id
    FG000
    title
    Anetumab Ravtansine (Experimental)
  2. description
    Active comparator
    id
    FG001
    title
    Vinorelbine (Active Comparator)
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        15
      type
      Radiological progression
    2. reasons
      1. group Id
        FG000
        num Subjects
        54
      2. group Id
        FG001
        num Subjects
        23
      type
      Progressive disease - radiological
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Protocol Violation
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      type
      Physician Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Lack of Efficacy
    6. reasons
      1. group Id
        FG000
        num Subjects
        7
      2. group Id
        FG001
        num Subjects
        1
      type
      Death
    7. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    8. reasons
      1. group Id
        FG000
        num Subjects
        44
      2. group Id
        FG001
        num Subjects
        13
      type
      Adverse Event
    9. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        5
      type
      Progressive disease - clinical
    10. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        2
      type
      Ongoing but not completed
    11. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        10
      type
      Not treated
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        166
      2. group Id
        FG001
        num Subjects
        82
      comment
      Randomized
      type
      STARTED
    2. achievements
      1. comment
        Safety analysis set
        group Id
        FG000
        num Subjects
        163
      2. comment
        Safety analysis set
        group Id
        FG001
        num Subjects
        72
      type
      Participants Received Treatment
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        166
      2. group Id
        FG001
        num Subjects
        82
      type
      NOT COMPLETED
    title
    Randomization and Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        2
      type
      Other
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      type
      No follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        2
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        5
      type
      Deterioration of general conditions
    6. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        102
      2. group Id
        FG001
        num Subjects
        45
      comment
      Safety follow-up performed
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        57
      2. group Id
        FG001
        num Subjects
        21
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        45
      2. group Id
        FG001
        num Subjects
        24
      type
      NOT COMPLETED
    title
    Safety Follow-up
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        30
      2. group Id
        FG001
        num Subjects
        22
      type
      Progressive disease - radiological
    2. reasons
      1. group Id
        FG000
        num Subjects
        8
      2. group Id
        FG001
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        0
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      type
      Progressive disease - clinical
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Deterioration of general conditions
    6. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        1
      type
      Ongoing but not completed
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        48
      2. group Id
        FG001
        num Subjects
        26
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        48
      2. group Id
        FG001
        num Subjects
        26
      type
      NOT COMPLETED
    title
    Active Follow-up
  4. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        86
      2. group Id
        FG001
        num Subjects
        44
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        3
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        30
      2. group Id
        FG001
        num Subjects
        17
      type
      Ongoing but not completed
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        123
      2. group Id
        FG001
        num Subjects
        66
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        123
      2. group Id
        FG001
        num Subjects
        66
      type
      NOT COMPLETED
    title
    Long-term Follow-up
pre Assignment Details
Overall, 315 patients were screened; of these, 67 patients were screening failures.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice